QPPV.COM KNOWLEDGE ASSESSMENT

Knowledge Assessment: GVP Module VI Case Intake, Triage and Initial Assessment

Test your understanding of the concepts covered by GVP Module VI: Case Intake, Triage and Initial Assessment.

Question 1 of 10Pass mark: 80%

Question 1 of 10 A notification says, 'The patient died while taking Product X.' What is the most appropriate intake interpretation?

The cause of death is established as an adverse reaction to Product X. The report should be ignored because death is an outcome rather than an event. The information should be preserved and appropriately escalated without inventing a cause of death or adverse reaction. The report should be coded as non-serious until a death certificate is received.

Question 2 of 10 What is the fundamental distinction between triage and validation?

Triage determines whether minimum ICSR criteria are met, whereas validation determines urgency. Triage determines how information should be routed and prioritised, whereas validation determines whether minimum criteria for a valid ICSR are present. Triage is performed only by vendors, whereas validation is performed only by affiliates. Triage occurs after submission, whereas validation occurs before receipt.

Question 3 of 10 Which statement best describes the appropriate depth of initial assessment?

It should always reproduce the entire medical-review process before validation. It should establish enough information for correct routing and the next processing step, with depth proportionate to the source and workflow. It should be limited to assigning a case number without reviewing the content. It should determine final causality before any escalation.

Question 4 of 10 Which statement best describes the role of seriousness indicators during triage?

They replace the formal assessment of seriousness. They are irrelevant until after regulatory submission. They can support prioritisation and escalation while the final seriousness classification is established through appropriate assessment. They automatically establish that a report is a valid ICSR.

Question 5 of 10 A patient-support programme systematically collects adverse-event information from patients. How should the intake process treat the source?

Automatically classify every report as spontaneous because the patient provided the information. Preserve the patient-support-programme context because source classification affects subsequent processing and reporting pathways. Exclude the information from PV because it was collected through a programme. Classify it as a clinical-trial report unless a physician submitted it.

Question 6 of 10 An affiliate receives a potentially serious report several days before central PV receives it. What is the most appropriate organisational response?

Use the central database-entry date because that is the only date visible to PV. Ignore the affiliate receipt date because affiliates are outside the central PV organisation. Reconstruct the information pathway, determine the applicable awareness date, assess timeline impact and review whether similar transfers were affected. Delete the affiliate record to avoid conflicting dates.

Question 7 of 10 A product complaint includes information that a patient experienced a severe reaction after administration. Which process design is most appropriate?

Allow the quality function to decide whether PV assessment is necessary. Allow PV to ignore the complaint because quality owns the source communication. Connect quality and PV workflows so the complaint can be investigated while the clinical information is independently assessed for PV relevance. Create only a quality record because one communication cannot support two processes.

Question 8 of 10 A later communication contradicts the initial statement that a patient was hospitalised. What should happen to the initial triage decision?

It must remain unchanged because initial triage decisions are permanent. The later information should be ignored if the first communication was already logged. The information should be reassessed, with both the original and later accounts preserved and the resolution documented. The case should automatically be deleted as unreliable.

Question 9 of 10 A medical-information representative receives a product-use question and the caller also mentions that a patient developed severe symptoms after taking the product. What is the most appropriate initial action?

Close the enquiry as medical information because the original question was not an adverse-event report. Wait until the caller provides a complete clinical narrative before recording anything. Recognise the potential safety information, preserve the communication and route it through the defined PV process. Determine the final regulatory classification before forwarding the information.

Question 10 of 10 Which metric is most useful for evaluating the effectiveness of an intake control rather than merely measuring workload?

Total number of cases entered into the safety database. Number of employees in the PV department. Number of potential safety reports discovered through reconciliation or inspection outside the intended intake route. Number of fields available in the case-processing system.

Knowledge Assessment: GVP Module VI Case Intake, Triage and Initial Assessment

Cookie Settings